A comparison among the effects of donor-specific whole blood, bone marrow, and spleen leukocytes on allograft survival when combined with cyclosporine.
Gyopar
A F
AF
Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada.
Loertscher
R
R
Guttman
R D
RD
Tchervenkov
J I
JI
D000818:Animals; D016913:Blood Component Transfusion; D001782:Blood Donors; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology; D016030:Kidney Transplantation / Q000276:immunology; D008297:Male; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D013154:Spleen / Q000166:cytology; D014184:Transplantation, Homologous
D016572:Cyclosporine